Apellis Pharmaceuticals Inc

Apellis Pharmaceuticals Inc

APLS

Market Cap$2.29B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Apellis Pharmaceuticals IncApellis Pharmaceuticals Inc-10.2--136%3.72.9
$-40.45

Current Fair Value

321.5% downside

Overvalued by 321.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.29 Billion
Enterprise Value$2.41 Billion
Dividend Yield$0 (0%)
Earnings per Share$-1.6
Beta0.67
Outstanding Shares125,453,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-10.24
PEG-26.36
Price to Sales3.65
Price to Book Ratio18.26
Enterprise Value to Revenue3.27
Enterprise Value to EBIT-10.77
Enterprise Value to Net Income-11
Total Debt to Enterprise0.2
Debt to Equity2.86

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Apellis Pharmaceuticals Inc

CEO: Cedric Francois